Patents by Inventor Richard Lilly
Richard Lilly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240139029Abstract: The present technology is directed to adjustable shunts for treating glaucoma. In particular, some embodiments provide shunts having a plurality of individually actuatable flow control elements that can control the flow of fluid through associated ports and/or flow lumens. For example, each individually actuatable flow control element can be actuated to modify a flow of a corresponding port and/or flow lumen. The individually actuatable flow control elements may be actuated along a given actuation axis. A flow control assembly may include a plurality of flow control elements arranged about a collection region. Accordingly, the shunts described herein can be manipulated into a variety of configurations that provide different drainage rates based on a degree to which the ports and/or flow lumens are blocked or unblocked, therefore providing a titratable glaucoma therapy for draining aqueous from the anterior chamber of the eye.Type: ApplicationFiled: July 6, 2023Publication date: May 2, 2024Inventors: Robert Chang, Claudio Argento, Katherine Sapozhnikov, Tom Saul, Richard Lilly
-
Patent number: 11865283Abstract: The present technology is generally directed to adjustable shunting systems for draining fluid from a first body region to a second body region. The adjustable shunting systems include a flow control plate or cartridge for controlling the flow of fluid through the system. For example, the flow control plate can include a shape memory actuation assembly having one or more nitinol actuators for controlling the flow of fluid through the system. The flow control plate can further include a plurality of discrete sheets or layers adhered together to encase the shape memory actuation assembly. The discrete sheets or layers can form flow channels for directing fluid through the flow control plate.Type: GrantFiled: January 21, 2022Date of Patent: January 9, 2024Assignee: Shifamed Holdings, LLCInventors: Eric Schultz, Tom Saul, Michael Drews, Richard Lilly, Katherine Sapozhnikov, Robert Chang
-
Publication number: 20230381021Abstract: The present technology relates to adjustable shunting systems and methods. In some embodiments, the present technology includes an adjustable shunting system that includes a drainage element having an inflow portion configured for placement within a patient. The system can also include a flow control assembly having a gating element operably coupled to the outflow portion of the drainage element. The flow control assembly can further include a first actuation element and a second actuation element coupled to the gating element. The first and second actuation elements can be configured to selectively move the gating element relative to the outflow portion to control an amount of fluid flow therethrough. The first and second actuation elements can each extend less than entirely around a perimeter of the drainage element.Type: ApplicationFiled: March 16, 2023Publication date: November 30, 2023Inventors: Claudio Argento, Richard Lilly, Robert Chang, Katherine Sapozhnikov, Tom Saul
-
Publication number: 20230380840Abstract: An apparatus for treating an aneurysm includes an occlusion element configured to be releasably coupled to an elongate delivery shaft and having a distal end, a proximal end, and a longitudinal axis extending between the distal end and the proximal end, the occlusion element configured to be delivered in a collapsed configuration and further configured to expand to an expanded configuration, the occlusion element comprising an inverted mesh tube having an outer layer and an inner layer, the outer layer transitioning to the inner layer at an inversion fold located at or adjacent the distal end of the occlusion element, the inversion fold defining an inner diameter, the occlusion element further comprising a maximum outer diameter, wherein the inner diameter is between about 35% to about 85% of the maximum outer diameter, and wherein an outer diameter of the occlusion element increases along the longitudinal axis to the maximum outer diameter.Type: ApplicationFiled: May 25, 2020Publication date: November 30, 2023Inventors: EDGARD LUIZ RAMOS PEREIRA, OSAMA O. ZAIDAT, BRETT FOLLMER, THOMAS J. WOLFE, ARTURO ROSQUETA, AAMIR BADRUDDIN, RICHARD LILLY
-
Patent number: 11766355Abstract: The present technology relates to adjustable shunting systems and methods. In some embodiments, the present technology includes an adjustable shunting system that includes a drainage element having an inflow portion configured for placement within a patient. The system can also include a flow control assembly having a gating element operably coupled to the outflow portion of the drainage element. The flow control assembly can further include a first actuation element and a second actuation element coupled to the gating element. The first and second actuation elements can be configured to selectively move the gating element relative to the outflow portion to control an amount of fluid flow therethrough. The first and second actuation elements can each extend less than entirely around a perimeter of the drainage element.Type: GrantFiled: March 19, 2021Date of Patent: September 26, 2023Assignee: Shifamed Holdings, LLCInventors: Claudio Argento, Richard Lilly, Robert Chang, Katherine Sapozhnikov, Tom Saul
-
Publication number: 20230285192Abstract: The present technology is directed to implantable medical devices for draining fluid from a first body region to a second body region. Some embodiments of the present technology provide adjustable devices that are selectively titratable to provide various levels of therapy. For example, the adjustable devices can have a drainage element with a lumen extending therethrough, a flow control element, and an actuation assembly. The actuation assembly can drive movement of the flow control element to change a dimension of and/or a flow resistance through the lumen, thereby increasing or decreasing the relative drainage rate of aqueous from an eye. In some embodiments, the actuation assembly and the flow control element together operate as a ratchet mechanism that can selectively move the flow control element between a plurality of positions and lock the device in a desired configuration until further actuation of the actuation assembly.Type: ApplicationFiled: January 30, 2023Publication date: September 14, 2023Inventors: Robert Chang, Tom Saul, Claudio Argento, Eric Schultz, Katherine Sapozhnikov, Richard Lilly, Michael Drews
-
Patent number: 11737920Abstract: In particular, some embodiments provide shunts having a plurality of individually actuatable flow control elements that can control the flow of fluid through associated ports and/or flow lumens. For example, each individually actuatable flow control element can be actuated to modify a flow of a corresponding port and/or flow lumen. The individually actuatable flow control elements may be actuated along a given actuation axis. A flow control assembly may include a plurality of flow control elements arranged about a collection region. Accordingly, the shunts described herein can be manipulated into a variety of configurations that provide different drainage rates based on a degree to which the ports and/or flow lumens are blocked or unblocked, therefore providing a titratable glaucoma therapy for draining aqueous from the anterior chamber of the eye.Type: GrantFiled: February 18, 2021Date of Patent: August 29, 2023Assignee: Shifamed Holdings, LLCInventors: Robert Chang, Claudio Argento, Katherine Sapozhnikov, Tom Saul, Richard Lilly
-
Publication number: 20230263663Abstract: The present technology relates to intraocular shunting systems and methods. In some embodiments, the present technology includes intraocular shunting systems that include a drainage element having an inflow portion configured for placement within an anterior chamber of the eye outside of an optical field of view of the patient and an outflow portion configured for placement at a different location of the eye. The system can also include a flow control assembly having a rotational control element operably coupled to the drainage element. The flow control assembly can further include an actuation structure coupled to the rotational control element and configured to selectively change an orientation of the rotational control element. An amount of fluid through the inflow portion and/or the outflow portion can vary based on the selected orientation of the rotational control element.Type: ApplicationFiled: May 2, 2023Publication date: August 24, 2023Inventors: Tessa Bronez, David Batten, Robert Chang, Katherine Sapozhnikov, Claudio Argento, Tom Saul, Michael Drews, Eric Schultz, Richard Lilly
-
Publication number: 20230240891Abstract: The present technology is directed to adjustable flow glaucoma shunts and methods for making and using such devices. In many of the embodiments described herein, the shunts include a generally flat frame. The frame can include an elongated portion having a lumen extending therethrough and a bladder portion defining an interior chamber that is in fluid communication with the lumen. When implanted in a patient's eye, aqueous can drain from the anterior chamber to a target outflow location via the lumen and interior chamber. In some embodiments, the shunts include a flow control assembly positioned within the interior chamber of the bladder portion to control the flow of aqueous through the lumen.Type: ApplicationFiled: November 2, 2022Publication date: August 3, 2023Inventors: Richard Lilly, Claudio Argento, Katherine Sapozhnikov, Christopher J. Engelman, Jean Orth
-
Publication number: 20230233378Abstract: The present technology is directed to adjustable shunts for treating glaucoma. In particular, some embodiments provide shunts having a plurality of individually actuatable flow control elements that can control the flow of fluid through associated ports and/or flow lumens. For example, each individually actuatable flow control element can be actuated to block and/or unblock a corresponding port and/or flow lumen. Accordingly, the shunts described herein can be manipulated into a variety of configurations that provide different drainage rates based on whether the ports and/or flow lumens are blocked or unblocked, therefore providing a titratable glaucoma therapy for draining aqueous from the anterior chamber of the eye.Type: ApplicationFiled: November 2, 2022Publication date: July 27, 2023Inventors: Robert Chang, Katherine Sapozhnikov, Claudio Argento, Tom Saul, Richard Lilly
-
Publication number: 20230201544Abstract: The present technology is generally directed to adjustable shunting systems for draining fluid from a first body region to a second body region. The adjustable shunting systems include a flow control plate or cartridge for controlling the flow of fluid through the system. For example, the flow control plate can include a shape memory actuation assembly having one or more nitinol actuators for controlling the flow of fluid through the system. The flow control plate can further include a plurality of discrete sheets or layers adhered together to encase the shape memory actuation assembly. The discrete sheets or layers can form flow channels for directing fluid through the flow control plate.Type: ApplicationFiled: January 21, 2022Publication date: June 29, 2023Inventors: Eric Schultz, Tom Saul, Michael Drews, Richard Lilly, Katherine Sapozhnikov, Robert Chang
-
Publication number: 20230200817Abstract: An apparatus for treating an aneurysm includes an occlusion element configured to be releasably coupled to an elongate delivery shaft and having a distal end, a proximal end, and a longitudinal axis extending between the distal end and the proximal end, the occlusion element configured to be delivered in a collapsed configuration and further configured to expand to an expanded configuration, the occlusion element comprising an inverted mesh tube having an outer layer and an inner layer, the outer layer transitioning to the inner layer at an inversion fold located at or adjacent the distal end of the occlusion element, the inversion fold defining an inner diameter, the occlusion element further comprising a maximum outer diameter, wherein the inner diameter is between about 35% to about 85% of the maximum outer diameter, and wherein an outer diameter of the occlusion element increases along the longitudinal axis to the maximum outer diameter.Type: ApplicationFiled: May 25, 2020Publication date: June 29, 2023Inventors: EDGARD LUIZ RAMOS PEREIRA, OSAMA O. ZAIDAT, BRETT FOLLMER, THOMAS J. WOLFE, ARTURO ROSQUETA, AAMIR BADRUDDIN, RICHARD LILLY
-
Publication number: 20230086856Abstract: In particular, some embodiments provide shunts having a plurality of individually actuatable flow control elements that can control the flow of fluid through associated ports and/or flow lumens. For example, each individually actuatable flow control element can be actuated to modify a flow of a corresponding port and/or flow lumen. The individually actuatable flow control elements may be actuated along a given actuation axis. A flow control assembly may include a plurality of flow control elements arranged about a collection region. Accordingly, the shunts described herein can be manipulated into a variety of configurations that provide different drainage rates based on a degree to which the ports and/or flow lumens are blocked or unblocked, therefore providing a titratable glaucoma therapy for draining aqueous from the anterior chamber of the eye.Type: ApplicationFiled: February 18, 2021Publication date: March 23, 2023Inventors: Robert Chang, Claudio Argento, Katherine Sapozhnikov, Tom Saul, Richard Lilly
-
Publication number: 20230092196Abstract: The present technology relates to adjustable shunting systems and methods. In some embodiments, the present technology includes an adjustable shunting system that includes a drainage element having an inflow portion configured for placement within a patient. The system can also include a flow control assembly having a gating element operably coupled to the outflow portion of the drainage element. The flow control assembly can further include a first actuation element and a second actuation element coupled to the gating element. The first and second actuation elements can be configured to selectively move the gating element relative to the outflow portion to control an amount of fluid flow therethrough. The first and second actuation elements can each extend less than entirely around a perimeter of the drainage element.Type: ApplicationFiled: March 19, 2021Publication date: March 23, 2023Inventors: Claudio Argento, Richard Lilly, Robert Chang, Katherine Sapozhnikov, Tom Saul
-
Patent number: 11596550Abstract: The present technology is directed to implantable medical devices for draining fluid from a first body region to a second body region. Some embodiments of the present technology provide adjustable devices that are selectively titratable to provide various levels of therapy. For example, the adjustable devices can have a drainage element with a lumen extending therethrough, a flow control element, and an actuation assembly. The actuation assembly can drive movement of the flow control element to change a dimension of and/or a flow resistance through the lumen, thereby increasing or decreasing the relative drainage rate of aqueous from an eye. In some embodiments, the actuation assembly and the flow control element together operate as a ratchet mechanism that can selectively move the flow control element between a plurality of positions and lock the device in a desired configuration until further actuation of the actuation assembly.Type: GrantFiled: April 16, 2021Date of Patent: March 7, 2023Assignee: Shifamed Holdings, LLCInventors: Robert Chang, Tom Saul, Claudio Argento, Eric Schultz, Katherine Sapozhnikov, Richard Lilly, Michael Drews
-
Patent number: 11529258Abstract: The present technology is directed to adjustable shunts for treating glaucoma. In particular, some embodiments provide shunts having a plurality of individually actuatable flow control elements that can control the flow of fluid through associated ports and/or flow lumens. For example, each individually actuatable flow control element can be actuated to block and/or unblock a corresponding port and/or flow lumen. Accordingly, the shunts described herein can be manipulated into a variety of configurations that provide different drainage rates based on whether the ports and/or flow lumens are blocked or unblocked, therefore providing a titratable glaucoma therapy for draining aqueous from the anterior chamber of the eye.Type: GrantFiled: January 22, 2021Date of Patent: December 20, 2022Assignee: Shifamed Holdings, LLCInventors: Robert Chang, Katherine Sapozhnikov, Claudio Argento, Tom Saul, Richard Lilly
-
Publication number: 20220387217Abstract: The present technology is directed to adjustable flow glaucoma shunts, systems, and methods for making and using such devices. In many of the embodiments described herein, the shunts include a drainage element configured to fluidly couple an anterior chamber of an eye and a target outflow location, such as a subconjunctival bleb space. The shunts can further include a flow control assembly coupled to the drainage element and configured to control the flow of fluid (e.g., aqueous) therethrough. The shunts can further include an outer membrane or bladder that encases the flow control assembly. The outer membrane can include a plurality of apertures that fluidly couple an interior of the outer membrane with an environment exterior to the outer membrane.Type: ApplicationFiled: October 9, 2020Publication date: December 8, 2022Inventors: Claudio Argento, Katherine Sapozhnikov, Richard Lilly, Christopher J. Engelman, Jean Orth
-
Publication number: 20220387216Abstract: The present technology relates to intraocular shunting systems and methods. In some embodiments, the present technology includes intraocular shunting systems that include a drainage element having an inflow portion configured for placement within an anterior chamber of the eye outside of an optical field of view of the patient and an outflow portion configured for placement at a different location of the eye. The system can also include a flow control assembly having a rotational control element operably coupled to the drainage element. The flow control assembly can further include an actuation structure coupled to the rotational control element and configured to selectively change an orientation of the rotational control element. An amount of fluid through the inflow portion and/or the outflow portion can vary based on the selected orientation of the rotational control element.Type: ApplicationFiled: March 2, 2022Publication date: December 8, 2022Inventors: Eric Schultz, Robert Chang, Tom Saul, Richard Lilly, Michael Drews, Claudio Argento, Katherine Sapozhnikov
-
Patent number: 11517477Abstract: The present technology is directed to adjustable flow glaucoma shunts and methods for making and using such devices. In many of the embodiments described herein, the shunts include a generally flat frame. The frame can include an elongated portion having a lumen extending therethrough and a bladder portion defining an interior chamber that is in fluid communication with the lumen. When implanted in a patient's eye, aqueous can drain from the anterior chamber to a target outflow location via the lumen and interior chamber. In some embodiments, the shunts include a flow control assembly positioned within the interior chamber of the bladder portion to control the flow of aqueous through the lumen.Type: GrantFiled: October 9, 2020Date of Patent: December 6, 2022Assignee: Shifamed Holdings, LLCInventors: Richard Lilly, Claudio Argento, Katherine Sapozhnikov, Christopher J. Engelman, Jean Orth
-
Publication number: 20220339035Abstract: The present technology is directed to adjustable flow glaucoma shunts and methods for making and using such devices. In many of the embodiments described herein, the shunts include a generally flat frame. The frame can include an elongated portion having a lumen extending therethrough and a bladder portion defining an interior chamber that is in fluid communication with the lumen. When implanted in a patient's eye, aqueous can drain from the anterior chamber to a target outflow location via the lumen and interior chamber. In some embodiments, the shunts include a flow control assembly positioned within the interior chamber of the bladder portion to control the flow of aqueous through the lumen.Type: ApplicationFiled: October 9, 2020Publication date: October 27, 2022Inventors: Richard Lilly, Claudio Argento, Katherine Sapozhnikov, Christopher J. Engelman, Jean Orth